Literature DB >> 1985402

Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of beta-carotene or vitamin A.

H F Stich1, B Mathew, R Sankaranarayanan, M K Nair.   

Abstract

Participants in the intervention trials were fishermen (Kerala, India), who chewed tobacco-containing betel quids daily before and throughout the study period. Frequency of oral leukoplakia, micronuclei in oral mucosal cells, and alterations in nuclear textures were used as endpoints. Administration of vitamin A (60 mg/wk) for 6-mo resulted in complete remission of leukoplakias in 57% and a reduction of micronucleated cells in 96% of tobacco-chewers. beta-carotene (2.2 mmol/wk) induced remission of leukoplakia in 14.8% and reduction of micronucleated cells in 98%. Vitamin A completely suppressed and beta-carotene suppressed by 50% formation of new leukoplakia within the 6-mo trial period. After withdrawal of vitamin A or beta-carotene treatment, oral leukoplakias reappeared, frequency of micronuclei in oral mucosa increased, and nuclear textures reverted to those present before the administration of chemo-preventive agents. The protective effect of the original treatment could be maintained for at least 8 additional months by administration of lower doses of vitamin A or beta-carotene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985402     DOI: 10.1093/ajcn/53.1.298S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Antioxidant vitamins and chemoprevention.

Authors:  H Lal; R Pandey; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  1999-01

2.  Plasma levels of beta-carotene are inversely correlated with circulating neutrophil counts in young male cigarette smokers.

Authors:  V L Van Antwerpen; A J Theron; G A Richards; C A Van der Merwe; E Viljoen; R Van der Walt; R Anderson
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

3.  A comparison of vitamin A and leucovorin for the prevention of methotrexate-induced micronuclei production in rat bone marrow.

Authors:  Sampath Madhyastha; Latha V Prabhu; V Saralaya; Rajalakshmi Rai
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.